| index | Title |
| 1 | Tumor immune checkpoints and their associated inhibitors Author(s):Zerui GAO, Xingyi LING, Chengyu SHI, Ying WANG, Aifu LIN Clicked:4256 Download:3891 Cited:0 <Full Text> <PPT> 1659 Journal of Zhejiang University Science B 2022 Vol.23 No.10 P.823-843 DOI:10.1631/jzus.B2200195 |
| 2 | USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer Author(s):Dexin YANG, Yuqin FENG, Haohua LU, Kelie CHEN, Jinming XU, Peiwei LI, Tianru WANG, Dajing XIA, Yihua WU Clicked:4020 Download:4807 Cited:0 <Full Text> <PPT> 1955 Journal of Zhejiang University Science B 2023 Vol.24 No.2 P.143-156 DOI:10.1631/jzus.B2200292 |
| 3 | Immune checkpoint blockade for cancer therapy: current progress and perspectives Author(s):Hongying YE, Weijie LIAO, Jiongli PAN, Yin SHI, Qingqing WANG Clicked:3491 Download:7396 Cited:0 <Full Text> <PPT> 994 Journal of Zhejiang University Science B 2025 Vol.26 No.3 P.203-226 DOI:10.1631/jzus.B2300492 |
| 4 | Roles of macrophages in tumor immunotherapy: metabolism, immune checkpoints, and combination strategies Author(s):Shan WANG1,2*, Yage FU1,2*, Yamei HUANG1 Clicked:2495 Download:2186 Cited:0 <Full Text> Journal of Zhejiang University Science B In Press DOI: |
